The 1st Annual Cell Therapy Industry Summit will provide an excellent opportunity for thought leaders to celebrate cell therapy industry achievements and disseminate best practices. The meeting is designed specifically to serve the networking and informational needs of cell therapy industry leaders and limited in attendance to ensure participants are able to engage in meaningful discussions about mutually beneficial industry trends, dynamics and opportunities.
A copy of the event agenda is below.
To register for the event, please visit: www.spgeventformer.com
For additional details, please contact Aruna Rani Mor at aruna.mor@lifetech.com.
THURSDAY, NOVEMBER 12
7:00am - 8:00am Breakfast
8:00am - 10:00am Session 1: Leading in regenerative medicine.
• Shaping the regulatory environment through scientific excellence
• Personalized medicine in action
• Driving shareholder value through cell therapy
Moderator:
Greg Lucier, Life Technologies Corporation
Speakers:
Tom Okarma, Geron Corporation
Geoff MacKay, Organogenesis, Inc
Eduardo Bravo, Cellerix
10:00am - 10:30am Morning Coffee
10:30am - 12:00pm Session 2: Stepping into regenerative medicine.
• Growth opportunities in cell therapy
• Barriers investment in cell therapy
• Partnership models for success
Moderator:
Paul Pickering, Life Technologies Corporation
Speakers:
Tom Novak, Roche Palo Alto
Rajesh Chopra, Celgene Corporation
Neil K. Warma, Opexa Therapeutics, Inc
12:00pm - 1:00pm Lunch
1:00pm - 2:30pm Breakout Sessions
Session 1:
Gene modification
Gene modification systems and processes, vector design and production issues, safety and regulatory concerns, and the future of cell-based gene therapy
Moderator:
Mark Bonyhadi, Life Technologies Corporation
Speakers:
Dave DiGuisto, City of Hope
Weng Tao, Neurotech
Edward Lanphier, Sangamo BioSciences, Inc
James Noble, Adaptimmune Ltd.
Session 2:
Stem cell scale up
Scale up considerations and technologies critical for providing stem cells at phase appropriate levels to support development from pre-clinical evaluations through commercialization
Moderator:
Eric Roos, Life Technologies Corporation
Speakers:
Ralph Brandenberger, Geron Corporation
Wouter Vant Hof, Athersys, Inc
Allan Robins, Novocell, Inc
Session 3:
More with less
Efforts to economize cell therapy manufacturing through items such as raw material sourcing, process efficiencies and automation.
Moderator:
Brian Newsom, Life Technologies Corporation
Speakers:
Katie Faria, Organogenesis
Ron Jankowski, Cook MyoSite
Juliana Blum, Humancyte
Jason Krentz, Tengion, Inc.
2:30pm - 3:00pm Afternoon Break
3:00pm - 5:00pm Session 4: Models for expedited commercialization.
• Opportunities for expedited regulatory clearance
• Novel go-to-market strategies
• Cash flow positive business models which build to therapeutic outcomes
Moderator:
Joydeep Goswami, Life Technologies Corporation
Speakers:
Greg McGarrell, MedCell Bioscience Limited
Dushyant Pathak, iPierian, Inc.
Kenneth K. Kleinhenz, Cytori Therapeutics
5:30pm - 8:00pm Networking reception and Dinner
FRIDAY, NOVEMBER 13
7:00am - 8:00am Breakfast
8:00am - 10:00am Session 1: Expanding your business with novel cell therapy platforms.
• Point of care for autologous therapy
• Novel differentiated cell populations
• Mobilization of endogenous progenitor
Moderator:
Mahendra Rao, Life Technologies Corporation
Speakers:
Deborah Eppstein, Q Therapeutics
Doris Taylor, University of Minnesota
Nicole Provost, Dendreon
10:00am - 10:30am Morning Coffee
10:30am - 12:00pm Session 2: Building a sustainable cell therapy business: The make vs. buy decision.
• Key parameters to consider in making your decision
• The influence of clinical development stage
• How to smooth the transition between manufacturing models
Moderator:
Nicolas Barthelemy, Life Technologies Corporation
Speakers:
Vern L. Liebmann, Aderans Research
Edward L. Field, Aldagen
Robert A. Preti, Progenitor Cell Therapy LLC
Michael Schuster, Angioblast Systems, Inc.
Fourth Annual Stem Cell Meeting on the Mesa
Category:Stem Cells on the Mesa
7:30 AM to 7:00 PM
2009 Stem Cell Meeting on the Mesa -- Wednesday, Nov. 11, 2009
Presented by The Sanford Consortium for Regenerative Medicine
Program Overview
San Diego's Torrey Mesa is becoming a worldwide leader in stem cell research. The 4th Annual Stem Cell Meeting on the Mesa is an exclusive, one-day symposium which draws together the pioneers responsible for advancing research towards discovering cures for debilitating diseases or injuries. This one-day event will feature renowned researchers from UC San Diego, The Salk Institute for Biological Studies, Burnham Institute for Medical Research, Harvard Medical School, Stanford School of Medicine and The Scripps Research Institute. These researchers will share their groundbreaking work in a series of four panels: Epigenetics, RNA, Clinical Applications of Stem Cell Research and iPSC.
As this year marks the five year anniversary of the passing of Proposition 71, which established the creation of the California Institute for Regenerative Medicine (CIRM) and designated $3 billion in funding for stem cell research and facilities in California, the event will feature a special awards recognition ceremony honoring key proponents of the proposition. Robert Klein, CIRM Chair, will recognize the following individuals:
• Steven Altman
• Lisa Altman
• Malin Burnham
• Dr. Edward Holmes
• Dr. Irwin Jacobs
• John Moores
• T. Denny Sanford
Who Should Attend
Students, researchers, policy makers, industry representatives, venture capitalists, law firms and patients who are interested in learning & networking with others to assess the current progression of stem cells in academia, government and industry.
Benefits of Attending
* COLLABORATE with and hear from a selection of scientific experts and industry professionals at the forefront of stem cell research.
* LEARN about today's hot topics in stem cell research from thought leaders at the cutting-edge of research.
* NETWORK with your colleagues and peers, as well as leading researchers from across the globe.
Confirmed Speakers Include
* Dr. Juan Carlos Izpisúa Belmonte, Professor, Gene Expression Laboratory, The Salk Institute for Biological Studies
* Roger Bingham, Co-Founder, The Science Network; Adjunct Professor, The Salk Institute for Biological Studies
* Patricia Churchland, Professor, Philosophy Department, UC San Diego
* Dr. Lawrence Goldstein, Director, Stem Cell Program, Professor, Cellular & Molecular Medicine, UC San Diego
* Dr. Richard Gregory, Assistant Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Harvard Stem Cell Institute; The Stem Cell Program at Children's Hospital Boston
* Wendy Levin, Associate Director Translational Medicine, Pfizer Oncology Business Unit
* Dr. Jeanne Loring, Professor of Developmental Neurobiology; Director, Center for Regenerative Medicine, The Scripps Research Institute
* Dr. Roel Nusse, Professor, Developmental Biology, Stanford School of Medicine
* Dr. John Reed, President & CEO, Professor and Donald Bren Presidential Chair, The Burnham Institute for Medical Research
Panel Chairs
* Epigenetics: Dr. Evan Snyder, Program Director, Professor, Stem Cells and Regenerative Medicine, The Burnham Institute for Medical Research
* RNA: Dr. Floyd Bloom, Professor Emeritus, The Scripps Research Institute
* Clinical Applications of Stem Cell Research: Dr. Catriona Jamieson, Director, Stem Cell Research Program, Moores UC San Diego Cancer Center, Assistant Professor, Medicine Hematologic Malignancies Program, UC San Diego
*iPSC: Dr. Alan Trounson, President, California Institute of Regenerative Medicine
Location
The Salk Institute for Biological Studies Frederic de Hoffmann Auditorium 10010 North Torrey Pines Rd La Jolla, CA 92037
» Map It!
Registration
To attend this event
» Register Now at events.connect.org,com_attend_events/id,91/task,view/
or contact Ilana Brand at ibrand@connect.org to RSVP.
Cost
$90 Non-affiliated attendees
$65 CONNECT & BIOCOM members
$35 Academic faculty & post docs
Free Undergraduate & graduate students (must bring respective school ID)
$100 At the Door
Questions?
Please contact Ilana Brand at 858.964.1314 or ibrand@connect.org
In Partnership With
BIOCOM
CONNECT
The Science Network
Lead Sponsor
Applied Biosystems
Invitrogen
VIP Dinner Sponsor
Stemgent, Inc.
Webcast Sponsor
Agilent Technologies
VIP Luncheon Sponsor
Molecular Diagnostic Systems
Young Innovator Poster Session Sponsor
Pfizer Inc.
About The Sanford Consortium for Regenerative Medicine The Sanford Consortium for Regenerative Medicine combines the intellectual resources of four of the world's leading biomedical research institutions to pursue collaborative research projects that advance the search for breakthrough cures. The Sanford Consortium unites San Diego's brightest researchers to work side by side to harness the regenerative power of stem cells to diagnose, treat and cure degenerative diseases and injuries. The Sanford Consortium integrates the collective knowledge of these foremost biomedical research institutions, with the support of surrounding industry and local community, to create a global resource for stem cell research.